Intra-abdominal Infection
📧 Sign up to get email alerts when something new happens for Intra-abdominal Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-04-07FDA Approved: CEFEPIME HYDROCHLORIDE AND DEXTROSE — Supplemental Application (B. Braun Medical Inc.)
FDA approved a supplemental application from B. Braun Medical Inc. for Cefepime hydrochloride and dextrose, adding this formulation under th…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Rezafungin Peritoneal Diffusion for Intra-abdominal Candidiasis
Clinical trial update for rezafungin evaluating peritoneal diffusion to treat intra-abdominal candidiasis; recruiting at a French center.
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Gelaspan vs Crystalloid Therapy in Sepsis [Phase 4]
Phase 4 clinical trial comparing Gelaspan to crystalloid therapy in patients with sepsis, including intra-abdominal infections; recruitment …
-
FDA approval · 2026-03-11FDA Approved: MEROPENEM — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Meropenem by Sandoz Inc, resulting in updated regulatory status for the product.
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: The Role of Circadian Clock Proteins in Innate and Adaptive Immunity [NA]
An ongoing clinical trial from Washington University School of Medicine is investigating the role of circadian clock proteins in innate and …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Innate Immune Response Monitoring Via Monocyte HLA-DR in Severe Intra-abdominal Infections at Risk of Fungal Infection
A clinical trial in France is monitoring innate immune response by measuring monocyte HLA-DR expression in patients with severe intra-abdomi…
-
CLINICAL_TRIALS trial_result · 2025-12-24Clinical Trial Update: Capillary Leak Index as a Prognostic Indicator for Post-Operative Abdominal Sepsis in Critically Ill Patients
Clinical trial results evaluate the Capillary Leak Index as a prognostic biomarker for post-operative abdominal sepsis in critically ill pat…
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: Phase I Study of Single/Multiple Ascending Doses of JKN2501 for Injection in Chinese Healthy Volunteers [Phase 1]
Phase 1 study update for JKN2501 in Chinese healthy volunteers to evaluate single/multiple ascending doses; study currently recruiting with …
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: A Phase 2 Study Evaluating Efficacy, Safety and Tolerability of Different Doses and Regimens of Allocetra-OTS for the Treatment of Organ Failure in Adult Sepsis Patients [Phase 2]
A Phase 2 study evaluating Allocetra-OTS for organ failure in adult sepsis patients has completed, examining efficacy, safety, and tolerabil…
-
CLINICAL_TRIALS trial_result · 2025-08-15Clinical Trial Update: INSPIRE Trial for Abdominal Infections [NA]
The INSPIRE trial evaluating treatment for intra-abdominal infection has completed. Results have been posted on 2025-08-15.
-
FDA approval · 2025-06-23FDA Approved: MEROPENEM — Original Application (BROOKS STERISCIENCE LIMITED)
FDA approved the original application for a generic meropenem product manufactured by Brooks SterisScience Limited.
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Diagnostic Performance of the CandID PLUS PCR for the Diagnosis of Intra-abdominal Candidiasis in Critically Ill Patients
This completed clinical trial assesses the diagnostic performance of the CandID PLUS PCR assay for intra-abdominal candidiasis in critically…
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: Performance of the SeptiCyte LAB Test for Antibiotic Stewardship in Mesenteric Ischemia
A completed clinical trial evaluated the performance of the SeptiCyte LAB diagnostic test to support antibiotic stewardship in patients with…
-
CLINICAL_TRIALS trial_result · 2025-02-20Clinical Trial Update: Intra-Abdominal Sepsis and Relationship Between Cumulative Fluid Balance and Serum Sodium and Chloride Levels and In-Hospital Mortality
A completed clinical trial evaluating the relationship between cumulative fluid balance, serum sodium and chloride levels, and in-hospital m…
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: Delayed Primary Closure Using Negative Pressure Wound Therapy [NA]
A clinical trial registered at ClinicalTrials.gov (NCT04042259) is evaluating delayed primary closure using negative pressure wound therapy …
-
FDA approval · 2024-10-25FDA Approved: METRONIDAZOLE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for metronidazole from Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals Inc. under an ANDA.
-
CLINICAL_TRIALS trial_result · 2024-10-22Clinical Trial Update: TriVerity in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections and Suspected Sepsis
This is an update on the TriVerity diagnostic trial for emergency department patients with suspected infections and suspected sepsis. The st…
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: Efficacy and Safety of CAZ-AVI in the Treatment of Infections Due to Carbapenem-resistant G- Pathogens in Chinese Adults [Phase 4]
Phase 4 trial results evaluate the efficacy and safety of ceftazidime-avibactam (CAZ-AVI) for carbapenem-resistant Gram-negative infections …
-
CLINICAL_TRIALS research · 2024-09-26Clinical Trial Update: Serum Calprotectin in Surgical Septic Patients
A clinical trial evaluating serum calprotectin as a biomarker in surgical patients with intra-abdominal infection and sepsis; currently recr…
-
FDA approval · 2024-08-22FDA Approved: AMPICILLIN AND SULBACTAM — Supplemental Application (Eugia US LLC)
FDA granted supplemental approval for Ampicillin and Sulbactam (AMPICILLIN AND SULBACTAM) submitted by Eugia US LLC.
-
FDA approval · 2024-07-22FDA Approved: MEROPENEM — Original Application (Qilu Antibiotics Pharmaceutical Co., Ltd.)
FDA approved the original application for Meropenem from Qilu Antibiotics Pharmaceutical Co., Ltd., authorizing sale of a generic Meropenem …
-
CLINICAL_TRIALS research · 2024-07-10Clinical Trial Update: Study Comparing Caspofungin to Placebo for the Treatment of ICU Intra-abdominal Candidiasis [Phase 3]
A Phase 3 clinical trial comparing caspofungin to placebo for treating ICU-associated intra-abdominal candidiasis, currently recruiting.
-
FDA approval · 2024-06-24FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for Amoxicillin and Clavulanate Potassium by Sandoz Inc to support changes to the approved gener…
-
FDA approval · 2024-06-18FDA Approved: METRONIDAZOLE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved a supplemental application for metronidazole from Heritage Pharmaceuticals Inc. (d/b/a Avet Pharmaceuticals Inc.) to modify…
-
FDA approval · 2024-05-01FDA Approved: PIPERACILLIN AND TAZOBACTAM — Supplemental Application (Civica, Inc.)
FDA approved a supplemental application for Civica, Inc. for Piperacillin and Tazobactam (piperacillin/tazobactam).